Literature DB >> 26260542

Vascular complications in autosomal dominant polycystic kidney disease.

Ronald D Perrone1, Adel M Malek2, Terry Watnick3.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. Relentless cyst growth substantially enlarges both kidneys and culminates in renal failure. Patients with ADPKD also have vascular abnormalities; intracranial aneurysms (IAs) are found in ∼10% of asymptomatic patients during screening and in up to 25% of those with a family history of IA or subarachnoid haemorrhage. As the genes responsible for ADPKDPKD1 and PKD2—have complex integrative roles in mechanotransduction and intracellular calcium signalling, the molecular basis of IA formation might involve focal haemodynamic conditions exacerbated by hypertension and altered flow sensing. IA rupture results in substantial mortality, morbidity and poor long-term outcomes. In this Review, we focus mainly on strategies for screening, diagnosis and treatment of IAs in patients with ADPKD. Other vascular aneurysms and anomalies—including aneurysms of the aorta and coronary arteries, cervicocephalic and thoracic aortic dissections, aortic root dilatation and cerebral dolichoectasia—are less common in this population, and the available data are insufficient to recommend screening strategies. Treatment decisions should be made with expert consultation and be based on a risk-benefit analysis that takes into account aneurysm location and morphology as well as patient age and comorbidities.

Entities:  

Mesh:

Year:  2015        PMID: 26260542      PMCID: PMC4904833          DOI: 10.1038/nrneph.2015.128

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  85 in total

Review 1.  Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis.

Authors:  Monique Hm Vlak; Ale Algra; Raya Brandenburg; Gabriël Je Rinkel
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

2.  Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease.

Authors:  Stefan Graf; Alexander Schischma; Knut E Eberhardt; Roland Istel; Birgit Stiasny; Bernd D Schulze
Journal:  Nephrol Dial Transplant       Date:  2002-05       Impact factor: 5.992

3.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

4.  Polycystin 1 is required for the structural integrity of blood vessels.

Authors:  K Kim; I Drummond; O Ibraghimov-Beskrovnaya; K Klinger; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

5.  Electrothrombosis of saccular aneurysms via endovascular approach. Part 1: Electrochemical basis, technique, and experimental results.

Authors:  G Guglielmi; F Viñuela; I Sepetka; V Macellari
Journal:  J Neurosurg       Date:  1991-07       Impact factor: 5.115

6.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

7.  Familial intracranial aneurysms.

Authors:  A M Lozano; R Leblanc
Journal:  J Neurosurg       Date:  1987-04       Impact factor: 5.115

8.  Intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  D Chauveau; Y Pirson; C Verellen-Dumoulin; A Macnicol; A Gonzalo; J P Grünfeld
Journal:  Kidney Int       Date:  1994-04       Impact factor: 10.612

9.  Characteristics of intracranial aneurysms in the else kröner-fresenius registry of autosomal dominant polycystic kidney disease.

Authors:  Hartmut P H Neumann; Angelica Malinoc; Janina Bacher; Zinaida Nabulsi; Vera Ivanovas; Nadine Ortiz Bruechle; Irina Mader; Michael M Hoffmann; Peter Riegler; Annette Kraemer-Guth; Christian Burchardi; Elke Schaeffner; Rodolfo S Martin; Pablo J Azurmendi; Klaus Zerres; Cordula Jilg; Charis Eng; Sven Gläsker
Journal:  Cerebrovasc Dis Extra       Date:  2012-10-09

10.  Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results.

Authors:  David M Hasan; Nohra Chalouhi; Pascal Jabbour; Aaron S Dumont; David K Kung; Vincent A Magnotta; William L Young; Tomoki Hashimoto; H Richard Winn; Donald Heistad
Journal:  J Am Heart Assoc       Date:  2013-02-22       Impact factor: 5.501

View more
  27 in total

Review 1.  Syndromes with aortic involvement: pictorial review.

Authors:  Evan J Zucker
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

2.  A case of cerebral infarction caused by painless acute aortic dissection in autosomal dominant polycystic kidney disease.

Authors:  Shintaro Yamaguchi; Shu Wakino; Hirobumi Tokuyama; Hiroshi Itoh
Journal:  CEN Case Rep       Date:  2020-01-27

3.  Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Irina M Sanchis; Shehbaz Shukoor; Maria V Irazabal; Charles D Madsen; Fouad T Chebib; Marie C Hogan; Ziad El-Zoghby; Peter C Harris; John Huston; Robert D Brown; Vicente E Torres
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-30       Impact factor: 8.237

4.  Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).

Authors:  Anna S Nikonova; Alexander Y Deneka; Anna A Kiseleva; Vladislav Korobeynikov; Anna Gaponova; Ilya G Serebriiskii; Meghan C Kopp; Harvey H Hensley; Tamina N Seeger-Nukpezah; Stefan Somlo; David A Proia; Erica A Golemis
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

Review 5.  Diagnostic approach and management of genetic aortopathies.

Authors:  Rohan Bhandari; Rajani D Aatre; Yogendra Kanthi
Journal:  Vasc Med       Date:  2020-02       Impact factor: 3.239

6.  Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

Authors:  Ao Li; Yuchen Xu; Song Fan; Jialin Meng; Xufeng Shen; Qian Xiao; Yuan Li; Li Zhang; Xiansheng Zhang; Guanqing Wu; Chaozhao Liang; Dianqing Wu
Journal:  JCI Insight       Date:  2018-03-08

7.  PCNT point mutations and familial intracranial aneurysms.

Authors:  Oswaldo Lorenzo-Betancor; Patrick R Blackburn; Emily Edwards; Rocío Vázquez-do-Campo; Eric W Klee; Catherine Labbé; Kyndall Hodges; Patrick Glover; Ashley N Sigafoos; Alexandra I Soto; Ronald L Walton; Stephen Doxsey; Michael B Bober; Sarah Jennings; Karl J Clark; Yan Asmann; David Miller; William D Freeman; James Meschia; Owen A Ross
Journal:  Neurology       Date:  2018-11-09       Impact factor: 9.910

8.  Capillary endothelia from two ADPKD patients are polyploidy.

Authors:  Sarmed H Kathem; Wissam A AbouAlaiwi; Xiaolin Zi; Surya M Nauli
Journal:  Ann Clin Cytol Pathol       Date:  2016-04-25

9.  A case of congenital left ventricular diverticulum in a patient with autosomal dominant polycystic kidney disease: possible mechanistic link between polycystin and ventricular diverticulum.

Authors:  Seishi Aihara; Shunsuke Yamada; Hidenori Matsusaka; Rami Tashiro; Hideaki Oka; Taro Kamimura; Atsumi Harada; Toshiaki Nakano; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  CEN Case Rep       Date:  2018-06-06

10.  Vasopressin-related copeptin is a novel predictor of early endothelial dysfunction in patients with adult polycystic kidney disease.

Authors:  Ismail Kocyigit; Mahmut Ilker Yilmaz; Ozkan Gungor; Eray Eroglu; Aydin Unal; Ozcan Orscelik; Bulent Tokgoz; Murat Sipahioglu; Ahmet Sen; Juan Jesús Carrero; Oktay Oymak; Jonas Axelsson
Journal:  BMC Nephrol       Date:  2016-11-30       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.